Beisi Xu

5.7k total citations
79 papers, 2.1k citations indexed

About

Beisi Xu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Beisi Xu has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 18 papers in Immunology and 9 papers in Oncology. Recurrent topics in Beisi Xu's work include Genomics and Chromatin Dynamics (22 papers), Epigenetics and DNA Methylation (15 papers) and Immune Cell Function and Interaction (12 papers). Beisi Xu is often cited by papers focused on Genomics and Chromatin Dynamics (22 papers), Epigenetics and DNA Methylation (15 papers) and Immune Cell Function and Interaction (12 papers). Beisi Xu collaborates with scholars based in United States, China and Japan. Beisi Xu's co-authors include Yiping Fan, John Easton, Guohui Li, David Finkelstein, Ying Shao, Geoffrey Neale, Yong‐Dong Wang, Xiang Chen, Seon Ah Lim and Yogesh Dhungana and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Beisi Xu

78 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beisi Xu United States 26 1.3k 493 390 209 188 79 2.1k
Maria-Magdalena Georgescu United States 17 1.8k 1.3× 495 1.0× 339 0.9× 139 0.7× 237 1.3× 29 2.5k
Elizabeth Bosch United States 9 1.2k 0.9× 531 1.1× 568 1.5× 156 0.7× 168 0.9× 12 2.0k
Maria A. Lagarkova Russia 22 1.2k 0.9× 349 0.7× 166 0.4× 143 0.7× 135 0.7× 124 1.9k
Lawryn H. Kasper United States 22 2.7k 2.0× 358 0.7× 501 1.3× 320 1.5× 387 2.1× 26 3.6k
Jiyang Yu United States 21 1.8k 1.3× 491 1.0× 511 1.3× 134 0.6× 305 1.6× 74 2.5k
Janelle Lauer United States 20 983 0.7× 378 0.8× 323 0.8× 149 0.7× 245 1.3× 33 1.9k
Neetu Gupta France 19 1.7k 1.3× 504 1.0× 298 0.8× 144 0.7× 175 0.9× 33 2.6k
Bill H. Chang United States 28 1.9k 1.4× 330 0.7× 645 1.7× 332 1.6× 424 2.3× 76 3.2k
Anna Golebiewska Luxembourg 23 1.1k 0.8× 285 0.6× 480 1.2× 114 0.5× 568 3.0× 42 2.1k
Jessica E. Hutti United States 18 1.1k 0.8× 417 0.8× 228 0.6× 71 0.3× 324 1.7× 25 1.6k

Countries citing papers authored by Beisi Xu

Since Specialization
Citations

This map shows the geographic impact of Beisi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beisi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beisi Xu more than expected).

Fields of papers citing papers by Beisi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beisi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beisi Xu. The network helps show where Beisi Xu may publish in the future.

Co-authorship network of co-authors of Beisi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Beisi Xu. A scholar is included among the top collaborators of Beisi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beisi Xu. Beisi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norrie, Jacqueline L., Danielle R. Little, Abbas Shirinifard, et al.. (2025). Latent epigenetic programs in Müller glia contribute to stress and disease response in the retina. Developmental Cell. 60(8). 1199–1216.e7. 4 indexed citations
2.
Zhang, Yuanyuan, Y. L. Zhou, Hao Li, et al.. (2025). A cohort of mRNAs undergo high-stoichiometry NSUN6-mediated site-specific m5C modification. Nature Communications. 16(1). 6119–6119. 3 indexed citations
3.
He, Ming-Hong, Xinying Zong, Beisi Xu, et al.. (2024). Dynamic Foxp3–chromatin interaction controls tunable Treg cell function. The Journal of Experimental Medicine. 221(9). 7 indexed citations
4.
Zhang, Mengli, Shaela Wright, Xiaowen Chen, et al.. (2023). RNA-Binding Protein RBM5 Plays an Essential Role in Acute Myeloid Leukemia By Activating the Oncogenic Protein HOXA9. Blood. 142(Supplement 1). 4130–4130. 1 indexed citations
5.
Wright, Shaela, Xujie Zhao, Wojciech Rosikiewicz, et al.. (2023). Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens. Nature Communications. 14(1). 7464–7464. 4 indexed citations
6.
Tian, Cheng, Liyuan Li, Qingfei Pan, et al.. (2023). Spatiotemporal regulation of cholangiocarcinoma growth and dissemination by peritumoral myofibroblasts in a Vcam1-dependent manner. Oncogene. 42(15). 1196–1208. 2 indexed citations
7.
Minden‐Birkenmaier, Benjamin A., Olivia K. Travis, Wojciech Rosikiewicz, et al.. (2023). ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis. Science Advances. 9(1). eabq3951–eabq3951. 7 indexed citations
8.
Ho, Winson S., Beisi Xu, Raymond Wai‐Yin Sun, et al.. (2023). PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. Journal of Clinical Investigation. 133(6). 25 indexed citations
9.
Jiao, Jianqin, Flávia A. Graça, Maricela Robles‐Murguia, et al.. (2023). Modulation of protease expression by the transcription factor Ptx1/PITX regulates protein quality control during aging. Cell Reports. 42(1). 111970–111970. 9 indexed citations
10.
Dickerson, Kirsten, Chunxu Qu, Qingsong Gao, et al.. (2022). ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia. Blood Cancer Discovery. 3(3). 240–263. 9 indexed citations
11.
Zhao, Xujie, Ping Wang, Jonathan D. Diedrich, et al.. (2022). Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. Nature Communications. 13(1). 5401–5401. 8 indexed citations
12.
Rosikiewicz, Wojciech, Yurii Sedkov, Andrey Tvardovskiy, et al.. (2022). The MLL3/4 complexes and MiDAC co-regulate H4K20ac to control a specific gene expression program. Life Science Alliance. 5(11). e202201572–e202201572. 6 indexed citations
13.
Li, Jun, Beisi Xu, Ming-Hong He, et al.. (2021). Control of Foxp3 induction and maintenance by sequential histone acetylation and DNA demethylation. Cell Reports. 37(11). 110124–110124. 25 indexed citations
14.
Li, Hao, Dong Han, Beisi Xu, et al.. (2021). A dual role of human tRNA methyltransferase hTrmt13 in regulating translation and transcription. The EMBO Journal. 41(6). e108544–e108544. 16 indexed citations
15.
Jin, Hongjian, Beisi Xu, Shivendra V. Singh, et al.. (2021). KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma. Nature Communications. 12(1). 7204–7204. 31 indexed citations
16.
Zhang, Hao, Yang Zhang, Xinyue Zhou, et al.. (2020). Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen. eLife. 9. 27 indexed citations
17.
Tian, Liqing, Ying Shao, Stephanie Nance, et al.. (2019). Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia. Nature Communications. 10(1). 2789–2789. 17 indexed citations
18.
Vo, BaoHan T., Chunliang Li, David Finkelstein, et al.. (2018). Mouse medulloblastoma driven by CRISPR activation of cellular Myc. Scientific Reports. 8(1). 8733–8733. 16 indexed citations
19.
Zimmerman, Mark W., Yu Liu, Shuning He, et al.. (2017). MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification. Cancer Discovery. 8(3). 320–335. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026